Weaning from Mechanical Ventilation

Quick Answer

Weaning (or "liberation") from mechanical ventilation is the process of transitioning a mechanically ventilated patient to spontaneous, unassisted breathing. Successful weaning requires systematic assessment of readiness criteria (adequate oxygenation, hemodynamic stability, mental status, resolution of precipitating illness), followed by a Spontaneous Breathing Trial (SBT) using either T-piece or low-level pressure support ventilation (PSV 5-8 cmH₂O). The Rapid Shallow Breathing Index (RSBI = respiratory rate ÷ tidal volume) threshold of below 105 is the most validated weaning predictor. Patients are classified as simple (successful on first SBT), difficult (2-3 SBTs or up to 7 days), or prolonged weaning (greater than 3 SBTs or greater than 7 days). Key complications include extubation failure (reintubation within 48-72 hours), weaning-induced pulmonary edema (WiPO) in cardiac dysfunction, and ventilator-induced diaphragmatic dysfunction (VIDD). High-risk patients (COPD, heart failure, obesity, OSA) benefit from prophylactic non-invasive ventilation (NIV) or high-flow nasal oxygen (HFNC) immediately post-extubation. [1,2,3]

CICM Exam Focus

Written Exam (SAQ/MCQ)

High-Yield Topics:

Weaning readiness criteria and physiological rationale
RSBI calculation and interpretation (threshold below 105)
SBT protocols: T-piece vs PSV methods, duration (30-120 minutes)
Cuff leak test indications, technique, interpretation
Weaning classification: simple, difficult, prolonged (ICC 2007 definitions)
Causes of weaning failure: respiratory, cardiac, neurological, metabolic
Difficult weaning management: identify reversible factors, tracheostomy timing
Post-extubation respiratory support: NIV vs HFNC indications
Special populations: COPD (hypercapnia, NIV bridge), cardiac dysfunction (WiPO), obesity (OSA risk)

Common Stem Scenarios:

"A 68-year-old ventilated for 5 days with pneumonia. Describe your approach to assessing weaning readiness and conducting an SBT."
"Calculate and interpret RSBI. What are its limitations?"
"A patient fails their second SBT with rising heart rate and diaphoresis. List causes of weaning failure and immediate management."
"Discuss the evidence for early vs late tracheostomy in difficult weaning."

Viva/Oral Exam

Expected Knowledge:

Systematic approach to weaning assessment (ABCDEF bundle integration)
Physiology: intrathoracic pressure changes during PPV→spontaneous breathing, impact on preload/afterload
Evidence-based protocols: ATS/CHEST 2017 Liberation Guidelines
Risk stratification for extubation failure
Management algorithms for failed SBT
Tracheostomy timing and benefits in prolonged weaning

Viva Triggers:

Present weaning parameters and ask: "Is this patient ready for an SBT?"
Show arterial blood gas during SBT: "What does this tell you about weaning tolerance?"
Scenario: Patient passes SBT but you're concerned about post-extubation stridor. Discuss.
Ethical considerations in prolonged weaning and withdrawal of life support

Key Points

Core Concepts

Weaning Readiness Criteria (4 Domains): [4]
- Oxygenation: PaO₂/FiO₂ ≥150-200, FiO₂ ≤40-50%, PEEP ≤5-8 cmH₂O
- Hemodynamic stability: No/minimal vasopressors, HR below 120-140, SBP 90-160 mmHg
- Resolution of precipitating illness
Rapid Shallow Breathing Index (RSBI): [5]
- Formula: RSBI = Respiratory Rate (breaths/min) ÷ Tidal Volume (liters)
- Classic threshold: below 105 predicts weaning success
- Optimal threshold (higher specificity): below 76
- Measured during 1-minute period of minimal support (CPAP 5 cmH₂O or T-piece)
Spontaneous Breathing Trial (SBT) Methods: [6,7]
- Pressure Support (PSV 5-8 cmH₂O + PEEP 5): Preferred method, higher success rates, compensates for ETT resistance
- T-piece: More rigorous "stress test," better for cardiac assessment (removes PEEP effect)
- Duration: 30-120 minutes (most studies use 30-60 minutes)
- Failure criteria: RR greater than 35, SpO₂ below 90%, HR change greater than 20%, SBP greater than 180 or below 90 mmHg, agitation, diaphoresis, accessory muscle use
Weaning Classification (ICC 2007/WIND 2017): [8,9]
- Simple (Group 1): Successful extubation on first SBT (~55-60% of patients)
- Difficult (Group 2): 2-3 SBTs or up to 7 days to achieve successful extubation
- Prolonged (Group 3): greater than 3 SBTs or greater than 7 days of weaning, mortality greater than 30%
Cuff Leak Test: [10,11]
- Indication: Prolonged intubation (greater than 48 hours), traumatic intubation, large ETT, self-extubation attempts
- Method: Deflate cuff, measure difference between inspiratory and expiratory tidal volumes
- Positive test (low leak): below 110 mL or below 12-24% of tidal volume → high risk of post-extubation stridor
- Management: Corticosteroids (methylprednisolone 20-40 mg q6h or dexamethasone 5 mg q6h) for 4-24 hours before re-testing
Post-Extubation Respiratory Support: [12,13,14]
- High-risk patients (COPD, CHF, age greater than 65, weak cough, hypercapnia, obesity): Prophylactic NIV or HFNC
- HFNC: Superior to conventional oxygen in low-risk patients, better tolerated
- NIV: Superior in high-risk hypercapnic patients (COPD, obesity-hypoventilation)
- Combined approach: Alternating NIV (6-12 hours/day) + HFNC for first 48 hours reduces reintubation in highest-risk patients
Extubation Failure Risk Factors: [15]
- Incidence: 10-20% of planned extubations
- Mortality: 25-50% (vs 5% in successful extubation)
- Major predictors: Age greater than 65, weak cough (below 60 L/min peak flow), copious secretions, positive fluid balance, RSBI greater than 105, prolonged ventilation (greater than 7 days), multiple comorbidities

Clinical Overview

Epidemiology

Mechanical ventilation is a life-saving intervention required by approximately 40% of ICU patients. However, prolonged ventilation is associated with significant morbidity and mortality. [16]

Key Statistics:

Duration: Median ventilation duration 2-5 days; weaning process constitutes ~40% of total ventilation time [17]
Weaning outcomes: Simple weaning 55-60%, difficult weaning 25-30%, prolonged weaning 10-15% [8]
Extubation failure: 10-20% overall; increases to 20-40% in high-risk patients [15]
Reintubation mortality: 25-50% vs 5% in successful extubation [15]
Prolonged weaning mortality: 30-40% at ICU discharge, greater than 50% at 1 year [9]
Ventilator-induced diaphragmatic dysfunction (VIDD): Develops in 50-80% of mechanically ventilated patients within 18-48 hours [18]

Risk Factors for Difficult/Prolonged Weaning:

Advanced age (greater than 70 years)
Chronic respiratory disease (COPD, ILD)
Cardiac dysfunction (heart failure, ischemic heart disease)
Neuromuscular weakness (ICU-acquired weakness, critical illness myopathy/polyneuropathy)
Prolonged ventilation (greater than 7 days)
Sepsis and multiorgan failure
Metabolic disturbances (malnutrition, electrolyte abnormalities)
Delirium and cognitive impairment

Pathophysiology

Transition from Positive Pressure to Spontaneous Breathing

The shift from mechanical ventilation to spontaneous breathing represents a major physiological challenge affecting multiple organ systems. [19,20]

Respiratory System Changes

During Positive Pressure Ventilation (PPV):

Ventilator generates positive intrathoracic pressure during inspiration
Reduces work of breathing to near zero
May cause diaphragmatic atrophy and dysfunction (VIDD) with prolonged use
Positive pressure reduces venous return (preload)

During Spontaneous Breathing:

Diaphragm and accessory muscles generate negative intrathoracic pressure
Work of breathing increases dramatically (may increase 2-10 fold)
Oxygen consumption by respiratory muscles increases from 2-5% to 15-25% of total VO₂
Endotracheal tube adds 30-50% additional resistance to airflow

Cardiovascular Changes

Preload Effects: [21]

PPV: Positive intrathoracic pressure → ↓ venous return → ↓ RV preload
Spontaneous breathing: Negative intrathoracic pressure → ↑ venous return → ↑ RV preload
In cardiac dysfunction: Sudden increase in venous return can overwhelm failing ventricle

Afterload Effects: [22,23]

PPV: Positive intrathoracic pressure → ↓ LV transmural pressure → ↓ LV afterload
Spontaneous breathing: Negative intrathoracic pressure → ↑ LV transmural pressure → ↑ LV afterload (may increase by 5-15 mmHg)
Weaning-Induced Pulmonary Edema (WiPO): In patients with diastolic dysfunction or ischemic heart disease, sudden increase in afterload + increased preload → rapid rise in pulmonary capillary wedge pressure → flash pulmonary edema

Adrenergic Response:

Weaning stress triggers catecholamine release
Increases heart rate, blood pressure, myocardial oxygen demand
May precipitate myocardial ischemia in vulnerable patients

Ventilator-Induced Diaphragmatic Dysfunction (VIDD) [18,24]

Mechanisms:

Disuse atrophy: Diaphragm can lose 30-50% of fiber cross-sectional area within 18-69 hours of controlled mechanical ventilation
Oxidative stress: PPV generates reactive oxygen species → proteolysis of muscle contractile proteins
Mitochondrial dysfunction: Impaired ATP production
Protein degradation: Activation of calpain and caspase-3 proteolytic pathways

Clinical Impact:

Reduced diaphragmatic force generation (maximal inspiratory pressure)
Decreased diaphragmatic excursion on ultrasound
Primary cause of difficult weaning in otherwise stable patients

Neuromuscular Factors

ICU-Acquired Weakness (ICUAW): [25]

Critical Illness Polyneuropathy (CIP): Axonal degeneration of motor/sensory nerves
Critical Illness Myopathy (CIM): Direct muscle damage, especially with neuromuscular blockers + corticosteroids
Incidence: 30-60% of patients ventilated greater than 7 days
Impact: Inability to generate adequate inspiratory effort, weak cough, prolonged weaning

Assessment: Weaning Readiness

Systematic Approach: The Four Domains [4,26]

1. Oxygenation and Gas Exchange

Criteria:

PaO₂/FiO₂ ratio ≥150-200 mmHg (some protocols use ≥200)
FiO₂ ≤40-50%
PEEP ≤5-8 cmH₂O
pH ≥7.25 (tolerates compensated respiratory acidosis in COPD)
SpO₂ ≥90% on above settings

Rationale: Patient must maintain adequate oxygenation with minimal ventilator support. High FiO₂ or PEEP requirements suggest ongoing parenchymal lung disease or recruitability issues.

2. Hemodynamic Stability

Criteria:

No vasopressors, or minimal/stable doses (e.g., norepinephrine ≤0.1 mcg/kg/min)
Heart rate below 120-140 bpm, stable rhythm
Systolic blood pressure 90-160 mmHg without significant fluctuations
No active myocardial ischemia (ECG changes, troponin rise)

Rationale: Weaning increases cardiovascular stress. Hemodynamic instability suggests inadequate reserve to tolerate increased work of breathing and hemodynamic shifts.

3. Neurological and Airway Protection

Criteria:

Level of consciousness: Arousable, RASS score -1 to +1 (drowsy but arousable to alert)
Follows simple commands (e.g., "squeeze my hand," "open your eyes")
Intact airway protective reflexes: cough, gag
Manageable secretion burden (not requiring continuous suctioning)

Rationale: Patient must protect airway from aspiration and clear secretions effectively post-extubation.

4. Resolution of Precipitating Illness

Criteria:

Original indication for ventilation resolved or improving
No ongoing sepsis or septic shock
Metabolic parameters stable (electrolytes, particularly K⁺, Mg²⁺, PO₄³⁻)
Adequate nutrition (not severely malnourished)
Temperature below 38.5°C

Weaning Predictors

Rapid Shallow Breathing Index (RSBI) [5,27,28]

The Gold Standard Predictor

Formula:

RSBI = Respiratory Rate (breaths/min) ÷ Tidal Volume (liters)

Measurement Technique:

Place patient on minimal support (T-piece or CPAP 5 cmH₂O, no pressure support)
Allow 1-2 minutes for stabilization
Measure respiratory rate and tidal volume over 1 minute
Calculate ratio

Example:

Respiratory rate: 24 breaths/min
Tidal volume: 0.35 L (350 mL)
RSBI = 24 ÷ 0.35 = 68.6 → Predicts success

Interpretation:

RSBI below 105: Classic threshold (sensitivity 97%, specificity 64%) [5]
RSBI below 76: Optimal threshold (improved specificity 87%, sensitivity 83%) [28]
RSBI greater than 105: High likelihood of weaning failure

Physiological Rationale:

High respiratory rate with low tidal volumes indicates rapid, shallow breathing
Suggests respiratory muscle fatigue, poor lung compliance, or high respiratory drive
Combination predicts inability to sustain spontaneous breathing

Limitations:

Less predictive in COPD (chronic high respiratory rates)
Affected by anxiety, pain, metabolic acidosis
Does not assess cardiac function (risk of WiPO)
Low positive predictive value (~60%) despite high negative predictive value (~95%)

Maximal Inspiratory Pressure (PImax/NIF) [29]

Definition: Maximal negative pressure generated during forceful inspiration against occluded airway.

Technique:

Attach one-way valve allowing expiration only
Patient exhales to residual volume
Maximal inspiratory effort against closed valve for 20-25 seconds
Measure peak negative pressure

Threshold:

PImax more negative than -20 to -30 cmH₂O predicts success
More negative than -15 cmH₂O is minimal acceptable

Limitations:

Requires patient cooperation and coaching
Volitional test (effort-dependent)
Less commonly used than RSBI

Airway Occlusion Pressure (P0.1) [30,31]

Definition: Negative airway pressure generated in first 100 milliseconds of inspiratory effort against occluded airway.

Advantages:

Non-volitional (measures central respiratory drive)
Can be measured continuously on modern ventilators
Independent of patient cooperation

Interpretation:

P0.1 1.0-3.0 cmH₂O: Normal respiratory drive, favorable for weaning
P0.1 greater than 3.5-4.0 cmH₂O: Excessive respiratory drive, high work of breathing, predicts failure
P0.1 below 1.0 cmH₂O: Low respiratory drive (over-sedation, brainstem dysfunction)

Clinical Use:

Often combined with RSBI (P0.1/RSBI ratio) for improved accuracy
Useful in patients unable to cooperate with RSBI measurement

Diaphragm Ultrasound [32,33,34]

Emerging bedside tool for assessing diaphragmatic function

Parameters Measured:

1. Diaphragm Excursion (DE):

Measurement: M-mode ultrasound, subcostal view
Reflects diaphragmatic displacement during breathing
Threshold: DE greater than 1.0-1.4 cm predicts success
Limitation: Influenced by ventilator support level

2. Diaphragm Thickening Fraction (TF):

Measurement: B-mode, zone of apposition (8th-10th intercostal space, mid-axillary line)
Formula: TF = [(Thickness end-inspiration - Thickness end-expiration) ÷ Thickness end-expiration] × 100
Threshold: TF ≥20-30% predicts success
Advantage: Less affected by ventilator settings, reflects actual contractile effort

Clinical Application:

Daily monitoring to detect VIDD
During SBT to identify occult diaphragmatic fatigue
Combined with RSBI improves predictive accuracy

Spontaneous Breathing Trial (SBT)

Indications [2,4]

An SBT should be performed when patient meets all weaning readiness criteria (4 domains above). Current guidelines recommend daily SBT screening as part of liberation protocols.

SBT Methods [6,7,35]

Option 1: Pressure Support Ventilation (PSV) - PREFERRED

Settings:

Pressure support: 5-8 cmH₂O (compensates for endotracheal tube resistance)
PEEP: 5 cmH₂O (or 0 cmH₂O in some protocols)
FiO₂: Same as pre-SBT or ≤50%

Advantages:

Higher SBT success rates (82.3% vs 74.0% with T-piece in Subira Trial 2019) [7]
Better tolerated by patients
Mimics post-extubation work of breathing (tube removed = resistance removed)
Simple ventilator adjustment (no disconnection required)

Disadvantages:

May be "too easy," potential for false success in borderline patients
Does not remove PEEP effect on cardiac function

Option 2: T-Piece Trial

Setup:

Disconnect patient from ventilator
Attach T-piece circuit to endotracheal tube
Deliver humidified oxygen at desired FiO₂
No pressure support, no PEEP

Advantages:

More rigorous "stress test" of respiratory system
Patient performs 100% of work of breathing
Better for assessing cardiac function (removes PEEP → reveals occult heart failure)
If patient passes T-piece, high likelihood of extubation success

Disadvantages:

More exhausting for patients with low reserve
Higher failure rates may lead to "false failures"
Requires disconnection from ventilator

Option 3: CPAP (Continuous Positive Airway Pressure)

Settings:

CPAP 5 cmH₂O, no pressure support
Less commonly used than PSV or T-piece

SBT Duration [36]

Evidence-Based Recommendations:

30-60 minutes: Most common protocol, supported by majority of trials
120 minutes: Some protocols use 2-hour trials for higher certainty
No difference: 30-minute vs 120-minute trials show similar extubation success rates in most studies [36]

Practical Approach:

Start with 30 minutes
If patient shows signs of distress at 30 minutes, trial has failed
If patient comfortable at 30 minutes, can extend to 60-120 minutes for additional confidence, especially in high-risk patients

SBT Failure Criteria [4,37]

Respiratory:

Respiratory rate greater than 35 breaths/min for greater than 5 minutes
SpO₂ below 90% despite increased FiO₂
Increased work of breathing (accessory muscle use, paradoxical breathing, nasal flaring)
Diaphoresis

Cardiovascular:

Heart rate increase greater than 20% from baseline or greater than 140 bpm
Systolic blood pressure greater than 180 mmHg or below 90 mmHg
Arrhythmias (new onset atrial fibrillation, ventricular ectopy)
ECG changes suggesting ischemia

Neurological:

Decreased level of consciousness
Agitation, anxiety, severe distress
Inability to follow commands

Arterial Blood Gas (if obtained):

pH below 7.30 (acute respiratory acidosis)
PaCO₂ increase greater than 10 mmHg from baseline
PaO₂ below 50-60 mmHg on FiO₂ ≥50%

When to Stop:

Any of the above criteria met → Immediately return to full ventilatory support
Do not allow patient to "struggle through" the trial (risks exhaustion, cardiac ischemia)

Post-SBT Decision Making

SBT Success + Good Airway Protection → Proceed to Extubation

SBT Failure → Analyze Causes:

Return patient to comfortable ventilator settings
Systematic evaluation of failure etiology (see "Difficult Weaning" section)
Address reversible factors
Repeat daily SBT screen

Extubation Procedure

Pre-Extubation Assessment

Cuff Leak Test [10,11,38]

Indications (Perform in High-Risk Patients):

Prolonged intubation (greater than 48 hours)
Traumatic or multiple intubation attempts
Large endotracheal tube relative to patient size
History of airway surgery or known laryngeal pathology
Self-extubation attempts (airway trauma)
Fluid overload (laryngeal edema)

Quantitative Method (Preferred):

Set ventilator to volume control mode
Suction oropharynx and ETT thoroughly
Record delivered tidal volume (Vt inspiratory)
Deflate ETT cuff completely
Measure expired tidal volume over 6 breaths (allow stabilization)
Calculate leak volume: Vt (inspiratory) - Vt (expiratory)

Interpretation:

Passed (Low Risk): Leak volume greater than 110 mL or greater than 12-24% of tidal volume
Failed (High Risk): Leak volume below 110 mL or below 12% of tidal volume → Risk of post-extubation stridor

Qualitative Method:

Deflate cuff, occlude ETT end manually
Auscultate for audible air leak around tube
Less reliable than quantitative method

Management of Failed Cuff Leak Test:

Corticosteroids: [39]
- Methylprednisolone 20-40 mg IV q6h, OR
- Dexamethasone 5 mg IV q6h
- "Duration: 4-24 hours before re-testing"
- "Mechanism: Reduces laryngeal edema"
- "NNT: ~25 to prevent one post-extubation stridor event"
Delayed extubation: Repeat cuff leak test after steroid course
Prepare for difficult airway: If extubation must proceed, ensure difficult airway cart, experienced intubator at bedside

Limitations:

Moderate sensitivity (62%), good specificity (87%) [11]
Many patients with failed test still extubate successfully
False positives: secretions, ETT malposition, low respiratory effort

Airway Secretion Assessment

Cough Strength:

Subjective: Ask patient to cough, assess strength
Objective: Cough peak flow measurement
- "Threshold: greater than 60 L/min predicts successful secretion clearance [40]"
- "below 60 L/min: High risk of post-extubation respiratory failure due to secretion retention"

Secretion Burden:

Suctioning frequency (should be ≤q2-4h, not continuous)
Secretion volume and character

Extubation Checklist

Before removing tube:

SBT passed (30-120 minutes)
Patient alert, follows commands (RASS -1 to +1)
Strong cough, manageable secretions
Cuff leak test performed if indicated and passed (or steroids given if failed)
Hemodynamic stability maintained
Post-extubation respiratory support plan determined (HFNC vs NIV vs conventional oxygen)
Difficult airway equipment at bedside
Plan for re-intubation if needed (experienced provider available)
Patient positioned 30-45 degrees upright

Extubation Technique:

Explain procedure to patient
Suction oropharynx and ETT thoroughly
Pre-oxygenate with 100% FiO₂ for 1-2 minutes
Position patient 30-45 degrees upright
Deflate cuff completely
Ask patient to take deep breath and cough
Remove ETT rapidly during cough/exhalation (clears secretions)
Immediately apply oxygen or post-extubation support device
Encourage coughing and deep breathing
Monitor continuously for 30-60 minutes post-extubation

Post-Extubation Respiratory Support

Risk Stratification [12,13,41]

Low-Risk Patients

Simple weaning (first SBT passed)
Age below 65
No significant comorbidities (COPD, heart failure)
Single organ failure (respiratory only)
Good cough, minimal secretions
Short ventilation duration (below 48 hours)

Recommendation: Conventional oxygen therapy OR High-Flow Nasal Cannula (HFNC)

High-Risk Patients (≥1 of following)

Difficult/prolonged weaning
Age greater than 65
Cardiac dysfunction (heart failure, ischemic heart disease)
Chronic respiratory disease (COPD, ILD)
Weak cough (below 60 L/min peak flow)
Hypercapnia (PaCO₂ greater than 45 mmHg)
Multiple comorbidities
Positive fluid balance
Prolonged ventilation (greater than 7 days)

Recommendation: Prophylactic NIV OR combined NIV + HFNC

Modalities

High-Flow Nasal Cannula (HFNC) [12,42]

Mechanism:

Delivers heated, humidified oxygen at flow rates up to 60 L/min
Generates modest positive end-expiratory pressure (PEEP ~2-5 cmH₂O depending on flow and mouth closure)
Washes out CO₂ from nasopharyngeal dead space
Reduces work of breathing by 30-40%

Settings:

Flow rate: 30-60 L/min (titrate to comfort)
FiO₂: Titrate to SpO₂ ≥92-94%

Evidence:

Superior to conventional oxygen therapy in preventing reintubation (Hernández JAMA 2016) [12]
Non-inferior to NIV in low-to-moderate risk patients
Better tolerated than NIV (patients can eat, speak, expectorate)

Indications:

Low-risk patients as first-line
High-risk patients who cannot tolerate NIV mask
Combined with NIV in alternating protocol (see below)

Non-Invasive Ventilation (NIV) [13,43]

Mechanism:

Provides inspiratory pressure support (IPAP) and expiratory pressure (EPAP/PEEP) via mask
Augments tidal volumes, reduces work of breathing
Maintains airway patency (especially important in OSA)
Prevents atelectasis

Settings:

IPAP: 8-12 cmH₂O (titrate to tidal volume 6-8 mL/kg)
EPAP: 4-8 cmH₂O
Backup rate if using BiPAP ST mode
FiO₂: Titrate to SpO₂ ≥92-94%

Evidence:

Reduces reintubation rates in high-risk patients (especially COPD, hypercapnia) [43]
Most effective when started immediately post-extubation (prophylactic), not as rescue therapy
Alternating NIV + HFNC superior to HFNC alone in highest-risk patients (Thille JAMA 2019) [14]

Indications:

High-risk patients with hypercapnia (COPD, obesity-hypoventilation, neuromuscular)
Cardiac dysfunction (prevents WiPO by maintaining positive intrathoracic pressure)
Obesity with OSA risk

Contraindications:

Inability to protect airway
Excessive secretions
Facial trauma/burns
Hemodynamic instability
Agitation/poor mask tolerance

Combined NIV + HFNC Protocol [14]

For Highest-Risk Patients (≥4 risk factors):

Protocol:

NIV: At least 12 hours per day (divided sessions: 3-4 hours on, breaks for meals/rest)
HFNC: During breaks from NIV mask
Duration: First 48 hours post-extubation
Then transition to HFNC alone if stable

Evidence (Thille 2019):

Reintubation rate: 23.3% (combined) vs 38.8% (HFNC alone) in high-risk patients
Number needed to treat (NNT): 6-7

Difficult Weaning

Definition [8,9]

International Consensus Conference (ICC 2007) Classification:

Category	Definition	SBT Attempts	Duration	Outcomes
Simple Weaning	Successful first SBT, no reintubation	1	below 24 hours	55-60% of patients, low mortality
Difficult Weaning	Failed initial SBT, eventual success	2-3	Up to 7 days	25-30% of patients
Prolonged Weaning	Failed ≥3 SBTs or weaning greater than 7 days	greater than 3	greater than 7 days	10-15% of patients, 30-40% ICU mortality

Successful weaning: Free from mechanical ventilation for ≥48 hours post-extubation

Causes of Weaning Failure [44,45]

Systematic approach using "WEANABLE" mnemonic (adapted):

W - Work of Breathing (Increased)

Respiratory Mechanics:

Decreased lung compliance (fibrosis, ARDS, pulmonary edema)
Increased airway resistance (bronchospasm, secretions, airway edema)
Auto-PEEP/intrinsic PEEP (COPD, asthma, high minute ventilation)
Endotracheal tube resistance (small diameter, kinking)

Assessment:

Respiratory rate greater than 30-35
Accessory muscle use, paradoxical breathing
High minute ventilation (greater than 15 L/min)
P0.1 greater than 4.0 cmH₂O

Management:

Bronchodilators (albuterol, ipratropium)
Diuresis if fluid overload
Optimize PEEP to offset auto-PEEP in COPD
Chest physiotherapy, suctioning

E - Endocrine/Metabolic

Thyroid:

Hypothyroidism → reduced respiratory drive, muscle weakness
Hyperthyroidism → increased metabolic demand, tachycardia

Adrenal:

Adrenal insufficiency (especially if on prolonged corticosteroids)

Electrolytes:

Hypophosphatemia (most common): Impairs diaphragm contractility
Hypokalemia, hypomagnesemia: Muscle weakness
Hypercalcemia: Muscle weakness
Hypocalcemia: Tetany, increased neuromuscular excitability

Glucose:

Hyperglycemia: Increased CO₂ production from carbohydrate metabolism
Hypoglycemia: Impaired mental status, sympathetic response

Assessment:

Check TSH, free T4
Morning cortisol, ACTH stimulation test if indicated
Daily electrolytes (PO₄³⁻, K⁺, Mg²⁺, Ca²⁺)
Blood glucose monitoring

Management:

Replace electrolytes to high-normal ranges
Levothyroxine for hypothyroidism
Hydrocortisone for adrenal insufficiency
Glucose control (target 140-180 mg/dL)

A - Airway/Anxiety

Airway Issues:

Secretions (weak cough, aspiration risk)
Laryngeal edema (failed cuff leak test)
Vocal cord dysfunction
Tracheomalacia

Anxiety/Delirium:

Agitation increases work of breathing, VO₂
Delirium impairs cooperation with weaning

Assessment:

Secretion volume, character, cough strength
Cuff leak test
CAM-ICU for delirium
RASS for sedation/agitation

Management:

Aggressive pulmonary toilet, suctioning
Mucolytics (N-acetylcysteine nebulized)
Dexmedetomidine for agitation (preserves respiratory drive)
Treat delirium (address underlying causes, minimize sedation)

N - Neuromuscular Weakness [25,46]

Causes:

Ventilator-induced diaphragmatic dysfunction (VIDD) [18,24]
Critical illness polyneuropathy (CIP)
Critical illness myopathy (CIM)
Prolonged neuromuscular blockade
Pre-existing neuromuscular disease (myasthenia gravis, Guillain-Barré, muscular dystrophy)

Risk Factors:

Prolonged mechanical ventilation (greater than 7 days)
Sepsis, MODS
Neuromuscular blocking agents (NMBAs), especially with corticosteroids
Hyperglycemia
Immobility

Assessment:

Clinical: Inability to lift arms/legs against gravity (MRC score below 48/60)
PImax/NIF <-20 cmH₂O (low inspiratory force)
Diaphragm ultrasound: Low thickening fraction (below 20%), reduced excursion (below 1 cm)
Nerve conduction studies, EMG (if diagnosis uncertain)

Management:

Early mobilization, physical therapy (as soon as hemodynamically stable)
Avoid/minimize NMBAs (use train-of-four monitoring if required)
Glycemic control
Adequate nutrition (protein 1.2-2.0 g/kg/day)
Consider inspiratory muscle training (threshold loading devices)

A - Acidosis/Alkalosis

Metabolic Acidosis:

High anion gap: Lactic acidosis (sepsis, shock), ketoacidosis, uremia
Normal anion gap: Diarrhea, RTA
Increases respiratory drive to compensate → increased work of breathing → fatigue

Metabolic Alkalosis:

Diuretics, NG suction, corticosteroids
Shifts oxyhemoglobin dissociation curve left → impaired O₂ unloading
May blunt respiratory drive

Respiratory Acidosis:

Inadequate ventilation, CO₂ retention
Suggests ongoing respiratory failure

Assessment:

Arterial blood gas
Calculate anion gap: (Na⁺) - (Cl⁻ + HCO₃⁻)
Lactate level

Management:

Treat underlying cause
Metabolic acidosis: May require bicarbonate if pH below 7.15 and renal failure (controversial)
Metabolic alkalosis: Potassium and chloride replacement

B - Brain/Neurological

Impaired Central Drive:

Stroke (especially brainstem)
Traumatic brain injury
Sedative medications (benzodiazepines, opioids, propofol)
Anoxic brain injury

Assessment:

GCS, RASS score
Review sedation regimen
CT/MRI brain if indicated
P0.1 below 1.0 cmH₂O suggests low respiratory drive

Management:

Daily sedation interruption/awakening trials [47]
Minimize benzodiazepines (associated with delirium, prolonged ventilation)
Target RASS -1 to +1
Treat underlying neurological condition

L - Left Ventricular Dysfunction [21,22,23]

Weaning-Induced Pulmonary Edema (WiPO):

Mechanism:

Transition to spontaneous breathing → ↑ venous return (preload) + ↑ LV afterload
Failing left ventricle cannot handle increased workload
Left ventricular end-diastolic pressure (LVEDP) rises
Pulmonary capillary wedge pressure (PCWP) increases
Hydrostatic pulmonary edema

Risk Factors:

Known heart failure (HFrEF, HFpEF)
Ischemic heart disease
Diastolic dysfunction
Positive fluid balance
Elderly patients

Clinical Presentation During SBT:

Tachycardia, hypertension
Tachypnea, increased work of breathing
Hypoxemia
May see pulmonary crackles

Assessment:

BNP/NT-proBNP: Rise from start to end of SBT suggests cardiac etiology [48]
Echocardiography during SBT: Increased E/e' ratio (greater than 15), new wall motion abnormalities
Lung ultrasound: Appearance of B-lines during SBT (interstitial edema) [49]

Management:

Diuresis: "Dry weaning"
achieve negative fluid balance before SBT
- "Target: Even to -500 mL daily balance for 2-3 days pre-weaning"
Afterload reduction: ACE inhibitors, nitrates
Beta-blockers: Control heart rate, reduce myocardial O₂ demand (if stable)
NIV post-extubation: Maintains positive intrathoracic pressure, reduces afterload
Consider optimization of heart failure therapy before weaning attempts

E - Excessive Nutrition/Energy Imbalance

Overfeeding:

Excess carbohydrate → ↑ CO₂ production (VCO₂)
Increased minute ventilation required to eliminate CO₂
High respiratory quotient (RQ greater than 1.0)

Underfeeding/Malnutrition:

Muscle wasting (including respiratory muscles)
Impaired immune function, prolonged infection
Delayed wound healing

Refeeding Syndrome:

Hypophosphatemia, hypokalemia, hypomagnesemia after starting nutrition
Severe weakness, cardiac arrhythmias

Assessment:

Respiratory quotient: RQ = VCO₂ ÷ VO₂ (normal 0.8-0.85)
- RQ greater than 1.0 suggests overfeeding
Daily caloric intake vs requirements (indirect calorimetry if available)
Prealbumin, albumin (limited value, negative acute phase reactants)

Management:

Balanced nutrition: 20-25 kcal/kg/day (use actual body weight in obesity)
Protein: 1.2-2.0 g/kg/day (higher in critical illness)
Prefer high-fat, lower-carbohydrate formulas if RQ high
Avoid overfeeding

Management Strategies for Difficult Weaning

1. Daily Multidisciplinary Assessment

Weaning Rounds:

Physician, nurse, respiratory therapist, physiotherapist
Review daily SBT screen
Identify and address reversible factors
Set daily weaning goals

2. Protocolized Weaning [50,51]

Evidence:

Protocol-driven weaning (managed by nurses/respiratory therapists) reduces ventilation duration by 25-30% vs physician-directed [50]
Key components:
- Daily SBT screening
- Standardized SBT technique
- Standardized failure criteria
- Escalation pathway for failures

3. ABCDEF Bundle [52]

ICU Liberation Bundle:

A: Assess, prevent, manage pain
B: Both spontaneous awakening trials (SAT) and spontaneous breathing trials (SBT)
C: Choice of sedation (prefer propofol, dexmedetomidine over benzodiazepines)
D: Delirium assessment and management
E: Early mobility and exercise
F: Family engagement

Evidence:

Bundle compliance associated with improved survival, reduced delirium, shorter ventilation [52]

4. Sedation Management [47,53]

Daily Sedation Interruption/Awakening Trials:

Pause sedation daily until patient awakens
Immediately followed by SBT if patient meets criteria
Reduces ventilation duration by ~1-2 days [47]

Light Sedation Targets:

RASS -1 to +1 (drowsy but arousable to alert)
Avoid deep sedation (RASS -4 to -5) unless specific indication

Avoid Benzodiazepines:

Associated with delirium, prolonged ventilation, worse outcomes [53]
Prefer propofol, dexmedetomidine

5. Early Mobilization [54]

Benefits:

Reduces ICU-acquired weakness
Preserves muscle mass and function
Improves weaning success

Protocol:

Start passive range of motion day 1
Progress to active exercises, sitting, standing as tolerated
Continue through weaning process

Tracheostomy in Prolonged Weaning [55,56,57]

Timing Considerations

Early Tracheostomy: below 7-10 days post-intubation Late Tracheostomy: greater than 10-14 days post-intubation

Evidence [55,56]

TracMan Trial (JAMA 2013): [55]

Early tracheostomy (within 4 days) vs late (after 10 days if still ventilated)
No mortality difference at 30 days (30.8% vs 31.5%) or 2 years
Shorter ICU stay with early tracheostomy (median 13 vs 16 days)
Shorter sedation duration with early tracheostomy

Recent Meta-analyses: [56]

Early tracheostomy consistently reduces:
- Ventilator days
- ICU length of stay
- Sedation requirements
Does NOT reduce:
- Mortality
- VAP rates (inconsistent data)

Benefits of Tracheostomy

Physiological:

Reduced dead space (50-70 mL less than ETT)
Lower airway resistance (shorter, wider tube)
Reduced work of breathing (15-30% reduction)
Easier to clear secretions

Comfort/Care:

Reduced sedation requirements
Allows phonation (with speaking valve)
Oral nutrition possible
Better oral hygiene
Patient mobilization easier
Can leave ICU to step-down/weaning unit

Psychological:

Improved comfort, communication
Reduced delirium
Enhanced quality of life

Risks of Tracheostomy

Early (below 7 days):

Procedural: Bleeding (5-10%), pneumothorax (1-5%), tube misplacement
Stomal infection (5-15%)

Late (greater than 30 days):

Tracheal stenosis (1-2% with modern technique)
Tracheomalacia
Tracheoinnominate fistula (rare, below 1%, but often fatal)

"Wait and See" Consideration:

10-15% of patients slated for late tracheostomy extubate successfully before procedure
Avoids unnecessary surgery

Current Recommendations [57]

Consider Early Tracheostomy (Day 7-10) if:

High likelihood of prolonged ventilation (greater than 14-21 days) based on:
- Severe brain injury (GCS ≤8)
- High spinal cord injury (C1-C4)
- Severe ARDS (PaO₂/FiO₂ below 100)
- Multiple organ failure
- Failed multiple SBTs by day 7

Delay Tracheostomy (greater than 10-14 days) if:

Reasonable chance of extubation within 10-14 days
Uncertain prognosis
Severe coagulopathy (relative contraindication to procedure)

Patient/Family Discussion:

Explain benefits (comfort, communication, mobility)
Explain risks
Clarify that tracheostomy does NOT mean "giving up" or withdrawal of care
Majority of tracheostomy patients eventually decannulate

Special Populations

COPD and Hypercapnia [58,59]

Challenges

Chronic Respiratory Insufficiency:

Baseline hypercapnia with metabolic compensation (elevated HCO₃⁻)
Tolerance of higher PaCO₂ (50-60 mmHg may be baseline)
Intrinsic PEEP (auto-PEEP) from air trapping
Increased work of breathing due to hyperinflation

Weaning Failure Mechanisms:

Increased work of breathing → diaphragm fatigue
Auto-PEEP → difficult to trigger ventilator, increased inspiratory threshold
Cardiac dysfunction (cor pulmonale from chronic hypoxemia)

Management Strategies

1. Permissive Hypercapnia:

Accept higher PaCO₂ (45-55 mmHg) as long as pH ≥7.30-7.32
Focus on pH, not absolute PaCO₂ value
Chronic compensation allows tolerance

2. Offset Auto-PEEP:

Measure intrinsic PEEP (expiratory hold maneuver)
Set external PEEP to 80% of measured auto-PEEP
Reduces inspiratory threshold load, easier triggering

3. SBT Method:

Prefer PSV (5-8 cmH₂O) over T-piece
PSV compensates for ETT resistance, better tolerated
Monitor pH during SBT; failure if pH drops below 7.30

4. NIV as Weaning Bridge: [59]

Early Extubation to NIV:

For COPD patients who fail SBT but otherwise stable
Extubate directly to NIV (BiPAP) rather than prolonging IMV
Evidence: Reduces VAP, ICU stay, mortality in COPD [59]

Protocol:

BiPAP settings: IPAP 10-15 cmH₂O, EPAP 4-6 cmH₂O
Continuous for first 24 hours if possible
Gradually reduce duration as tolerated
Target: PaCO₂ near baseline, pH greater than 7.30

5. Address Comorbidities:

Optimize bronchodilators (albuterol, ipratropium)
Systemic corticosteroids if COPD exacerbation (prednisolone 30-40 mg/day × 5-7 days)
Diuresis if right heart failure/fluid overload
Nutrition (avoid overfeeding/high carbohydrate)

Cardiac Dysfunction and Weaning-Induced Pulmonary Edema [21,22,23,48]

Pathophysiology (Detailed)

Hemodynamic Shifts:

From PPV to Spontaneous Breathing:

Preload increases:
- Negative intrathoracic pressure → ↑ venous return
- RV preload ↑ → RV output ↑ → LV preload ↑
- In diastolic dysfunction: Stiff LV cannot accommodate increased preload → LVEDP ↑
Afterload increases:
- Negative intrathoracic pressure → ↑ LV transmural pressure
- Transmural pressure = LV systolic pressure - intrathoracic pressure
- Example: If intrathoracic pressure shifts from +5 (PPV) to -5 (spontaneous), effective afterload increases by 10 mmHg
- In systolic dysfunction: Failing LV cannot overcome increased afterload → ↓ stroke volume, ↑ LVEDP
Catecholamine surge:
- Stress of weaning → ↑ HR, ↑ BP, ↑ myocardial O₂ demand
- May precipitate myocardial ischemia → further worsens LV function

Result: LVEDP ↑ → PCWP ↑ → pulmonary edema

Diagnosis [48,49]

Clinical Clues During SBT:

Tachycardia (HR increase greater than 20 bpm)
Hypertension (SBP greater than 180 mmHg)
Tachypnea, increased work of breathing
Hypoxemia (SpO₂ drop)
Diaphoresis
May hear crackles on auscultation

Investigations:

BNP/NT-proBNP: [48]

Measure before and after SBT (or at time of SBT failure)
Significant rise (e.g., greater than 50% increase or greater than 300 pg/mL) suggests cardiac origin
Sensitivity 85%, specificity 80% for WiPO

Echocardiography During SBT:

Increased E/e' ratio (greater than 15 indicates elevated filling pressures)
New or worsening wall motion abnormalities (ischemia)
Reduced LVEF
Diastolic dysfunction parameters

Lung Ultrasound (LUS): [49]

Appearance of B-lines during SBT (vertical artifacts indicating interstitial edema)
Highly specific for pulmonary edema
Can be performed serially during SBT

Management

Pre-Weaning Optimization:

1. "Dry Weaning":

Aggressive diuresis 2-3 days before SBT attempt
Target: Negative fluid balance 500-1000 mL/day
Aim for even to slightly negative cumulative balance
Monitor daily weights, input/output

2. Optimize Heart Failure Therapy:

ACE inhibitors or ARBs (afterload reduction)
Beta-blockers (if stable, not in acute decompensation)
Treat myocardial ischemia (antiplatelet, statin, beta-blocker, consider cardiology consult)

3. Correct Anemia:

Target hemoglobin greater than 8-9 g/dL (possibly higher in ischemic heart disease)
Reduces cardiac output demand

During Weaning:

1. Vasodilators:

Nitroglycerin infusion during SBT (if hypertensive)
Reduces afterload and preload
Improves coronary perfusion

2. Gentle SBT Progression:

Use PSV rather than T-piece (maintains some positive pressure)
Shorter initial trials (30 minutes), extend gradually if tolerated
Consider gradual PSV reduction over days rather than single SBT

Post-Extubation:

1. Prophylactic NIV:

Maintain positive intrathoracic pressure
Reduces afterload surge
Prevents acute decompensation
Settings: CPAP 5-8 cmH₂O or BiPAP IPAP 10-12, EPAP 5-8 cmH₂O

2. Continue Diuretics:

Ongoing gentle diuresis post-extubation
Monitor for hypovolemia/hypotension

Obesity and Obstructive Sleep Apnea [60,61]

Physiological Challenges

Respiratory Mechanics:

↓ Functional Residual Capacity (FRC): Adipose tissue compresses lungs
↓ Lung and chest wall compliance: Increased elastic workload
Rapid desaturation with apnea (low FRC = low oxygen reserve)
Atelectasis in dependent lung zones (supine position)

OSA-Specific Risks:

Upper airway collapse post-extubation (reduced pharyngeal muscle tone)
Opioid sensitivity (respiratory depression)
Fluid shifts to neck in recumbent position → airway narrowing

Weaning Strategies

1. Positioning:

Semi-recumbent (30-45 degrees) or reverse Trendelenburg
Moves abdominal contents away from diaphragm
Improves FRC, reduces atelectasis
Essential during SBT and post-extubation

2. SBT Method:

Prefer PSV (8-10 cmH₂O) over T-piece
May need higher PEEP (8-10 cmH₂O) to prevent atelectasis
Sitting upright during trial

3. Cuff Leak Test:

Essential in obese patients (higher risk of difficult intubation and airway edema)
If failed: Corticosteroids before extubation

4. Post-Extubation Support (CRITICAL): [61]

High-risk for extubation failure: BMI greater than 35-40, known OSA

Prophylactic NIV/CPAP:

CPAP: For isolated OSA (maintains airway patency)
- "Settings: CPAP 8-12 cmH₂O (match home CPAP settings if known)"
BiPAP: For obesity-hypoventilation syndrome (OHS) or hypercapnia
- "Settings: IPAP 12-15 cmH₂O, EPAP 6-8 cmH₂O"
Duration: Continuous for first 24 hours if possible, especially overnight
Avoid excessive opioids: Use multimodal analgesia, regional techniques

HFNC as alternative:

If NIV not tolerated
Flow 50-60 L/min, FiO₂ titrated

5. Aggressive Pulmonary Toilet:

Incentive spirometry
Chest physiotherapy
Early mobilization (sitting, standing, ambulation)
Suctioning as needed (obese patients may have weak cough)

Neuromuscular Disease [62]

Specific Conditions

Guillain-Barré Syndrome (GBS):

Ascending paralysis affecting respiratory muscles
Weaning dependent on neurological recovery (weeks to months)
Autonomic instability (labile BP, arrhythmias) complicates weaning

Myasthenia Gravis:

Fatigable weakness worsens with repetitive effort
Weaning requires optimization of anticholinesterase therapy (pyridostigmine)
Consider plasmapheresis or IVIG if crisis

Amyotrophic Lateral Sclerosis (ALS), Muscular Dystrophy:

Progressive weakness, often cannot wean
Weaning attempts may be futile
Requires discussion about goals of care, tracheostomy, long-term ventilation

Assessment

Bedside Spirometry:

Vital capacity (VC): greater than 10-15 mL/kg needed for extubation
Negative inspiratory force (NIF): More negative than -20 to -30 cmH₂O

Diaphragm Ultrasound:

Thickening fraction, excursion

Serial Monitoring:

Frequent reassessment (daily or twice-daily) to detect recovery

Weaning Approach

Slow, Gradual Reduction:

May require weeks to months
Gradual PSV reduction (1-2 cmH₂O per day)
Avoid exhaustion with prolonged SBTs

Optimize Medical Therapy:

Disease-specific treatments
Physical therapy, respiratory muscle training

Tracheostomy:

Often required for prolonged weaning (greater than 14-21 days)
Facilitates transfer to weaning center or long-term care

Complications and Outcomes

Extubation Failure [15,63]

Definition: Need for reintubation within 48-72 hours of planned extubation

Incidence:

Overall: 10-20%
High-risk patients: 20-40%
Elderly (greater than 75 years): 25-30%

Mortality:

Reintubated patients: 25-50% ICU mortality
Successfully extubated: 5-10% ICU mortality
Extubation failure is an independent predictor of death [15]

Mechanisms of Increased Mortality:

Delay in reintubation → hypoxemia, cardiac arrest
Aspiration during respiratory distress pre-reintubation
Difficult/traumatic reintubation
Ventilator-associated pneumonia (VAP) with reintubation

Major Risk Factors: [63]

Age greater than 65 years (OR 2.5)
Weak cough, copious secretions (OR 3.0)
RSBI greater than 105 (OR 2.0)
Positive fluid balance in 24h pre-extubation (OR 1.8)
Underlying cardiac disease (OR 2.2)
Prolonged mechanical ventilation greater than 7 days (OR 2.0)
Failed cuff leak test (OR 5.0 for stridor)

Timing of Reintubation:

Median time to reintubation: 12-24 hours post-extubation
Early reintubation (below 12 hours): Often respiratory (hypoxemia, upper airway obstruction)
Late reintubation (12-72 hours): Often cardiac (pulmonary edema), aspiration, secretions

Management:

Do not delay reintubation if indicated
Early recognition of failure (close monitoring first 24-48 hours)
Have experienced intubator perform reintubation
Consider awake fiberoptic intubation if airway edema suspected

Summary: Systematic Weaning Approach

Step 1: Daily Weaning Screen (Every Morning)

Assess Four Domains:

✅ Oxygenation: PaO₂/FiO₂ ≥150-200, FiO₂ ≤40-50%, PEEP ≤5-8
✅ Hemodynamic: Stable, minimal/no pressors
✅ Neurological: Alert (RASS -1 to +1), follows commands
✅ Resolution of illness: Original condition improved

If ALL criteria met → Proceed to Step 2 If ANY criterion NOT met → Address issue, re-screen next day

Step 2: Measure RSBI

Minimal support (CPAP 5 or T-piece) × 1 minute
RSBI = RR ÷ Vt (liters)
RSBI below 105 → Proceed to SBT
RSBI ≥105 → Reconsider, may still attempt SBT if other factors favorable

Step 3: Spontaneous Breathing Trial

Method: PSV 5-8 cmH₂O + PEEP 5 (preferred) OR T-piece Duration: 30-60 minutes (extend to 120 if needed for confidence)

Monitor:

Respiratory rate, SpO₂, heart rate, blood pressure
Work of breathing (accessory muscles, diaphoresis)
Mental status

SBT Pass Criteria:

RR below 30-35, SpO₂ ≥90%
HR change below 20%, SBP 90-180
No distress, tolerates trial

SBT Fail → Return to full support, investigate cause (see Difficult Weaning section)

Step 4: Pre-Extubation Assessment

✅ Strong cough, manageable secretions
✅ Cuff leak test if indicated (passed or steroids given)
✅ Post-extubation support plan (HFNC vs NIV based on risk)
✅ Difficult airway equipment available

Step 5: Extubation

Position 30-45 degrees
Suction thoroughly
Remove ETT during cough/exhalation
Immediate oxygen/support device

Step 6: Post-Extubation Monitoring

First 24-48 hours CRITICAL:

Continuous monitoring (telemetry, pulse oximetry)
Respiratory rate, work of breathing
SpO₂ ≥92-94%
High-risk patients: Prophylactic NIV/HFNC per protocol

Reintubation if:

Severe respiratory distress
Hypoxemia (SpO₂ below 88-90% despite high FiO₂)
Respiratory acidosis (pH below 7.30)
Hemodynamic instability
Decreased consciousness

SAQ Practice Questions

SAQ 1: Weaning Readiness and RSBI

Question: A 62-year-old man has been mechanically ventilated for 6 days following severe community-acquired pneumonia. He is now improving. His current ventilator settings are: Pressure Support 10 cmH₂O, PEEP 5 cmH₂O, FiO₂ 35%. ABG shows: pH 7.42, PaCO₂ 38 mmHg, PaO₂ 92 mmHg, HCO₃⁻ 24 mmol/L. He is alert, following commands, hemodynamically stable on no vasopressors.

(a) List the four domains of weaning readiness. Does this patient meet criteria? (4 marks)

(b) Describe how to measure the Rapid Shallow Breathing Index (RSBI) in this patient. (3 marks)

(c) The measured RSBI is 68. Interpret this result and outline your next step. (3 marks)

Model Answer:

(a) Four Domains of Weaning Readiness (4 marks - 1 per domain):

Oxygenation:
- PaO₂/FiO₂ ≥150-200 mmHg (patient: 92/0.35 = 263 mmHg ✓)
- FiO₂ ≤40-50% (patient: 35% ✓)
- PEEP ≤5-8 cmH₂O (patient: 5 ✓)
- pH ≥7.25 (patient: 7.42 ✓)
- Criteria met ✓
Hemodynamic Stability:
- No/minimal vasopressors (patient: none ✓)
- HR below 120-140 bpm, stable
- SBP 90-160 mmHg
- Criteria met ✓
Neurological/Mental Status:
- Alert, arousable (RASS -1 to +1) (patient: alert ✓)
- Follows commands (patient: yes ✓)
- Intact airway protection
- Criteria met ✓
Resolution of Precipitating Illness:
- Original condition improving (pneumonia improving ✓)
- Criteria met ✓

Patient meets all four domains - ready for weaning trial.

(b) Measuring RSBI (3 marks):

Reduce ventilator support to minimal level: Place on CPAP 5 cmH₂O (no pressure support) OR T-piece with humidified oxygen (1 mark)
Stabilization period: Allow 1-2 minutes for patient's breathing pattern to stabilize (1 mark)
Measurement: Over 1 minute, measure:
- Respiratory rate (breaths/min)
- Tidal volume (liters)
- Calculate: RSBI = RR ÷ Vt (1 mark)

(c) Interpretation and Next Step (3 marks):

Interpretation:

RSBI = 68 (threshold for success is below 105, optimal below 76)
This predicts high likelihood of successful weaning (sensitivity 83%, specificity 87% for RSBI below 76) (1 mark)

Next Step:

Proceed to Spontaneous Breathing Trial (SBT) (1 mark)
Method: PSV 5-8 cmH₂O + PEEP 5 cmH₂O (preferred) OR T-piece trial
Duration: 30-60 minutes, monitoring for SBT failure criteria
If SBT successful → proceed to extubation (1 mark)

SAQ 2: Difficult Weaning - Cardiac Dysfunction

Question: A 70-year-old woman with ischemic heart disease (LVEF 35%) was intubated for flash pulmonary edema 3 days ago. She has failed two spontaneous breathing trials. During the trials, she becomes tachycardic (HR 130), hypertensive (BP 185/95), tachypneic (RR 32), and hypoxemic (SpO₂ 88%). The trial is stopped after 10 minutes.

(a) What is the most likely cause of her weaning failure? Explain the pathophysiology. (4 marks)

(b) Describe TWO investigations that could confirm your diagnosis. (2 marks)

(c) Outline FOUR management strategies to facilitate successful weaning in this patient. (4 marks)

Model Answer:

(a) Diagnosis and Pathophysiology (4 marks):

Diagnosis: Weaning-Induced Pulmonary Edema (WiPO) due to cardiac dysfunction (1 mark)

Pathophysiology (3 marks):

Mechanism:

During positive pressure ventilation (PPV): Positive intrathoracic pressure reduces LV preload (↓ venous return) AND reduces LV afterload (↓ transmural pressure) (1 mark)
During spontaneous breathing trial (SBT): Shift to negative intrathoracic pressure causes:
- "Increased preload: Negative pressure increases venous return → increased RV and LV filling"
- "Increased afterload: Negative intrathoracic pressure increases LV transmural pressure (pressure gradient LV must overcome) by 5-15 mmHg"
- "Catecholamine surge: Stress response increases HR, BP, myocardial O₂ demand (1 mark)"
In this patient with LV systolic dysfunction (LVEF 35%): The failing left ventricle cannot handle sudden increase in preload + afterload → LV end-diastolic pressure (LVEDP) rises → Pulmonary capillary wedge pressure (PCWP) increases → Hydrostatic pulmonary edema (1 mark)

(b) Investigations to Confirm (2 marks - 1 per investigation):

B-type Natriuretic Peptide (BNP or NT-proBNP):
- Measure before and after (or during) SBT
- Significant rise (greater than 50% increase or absolute value greater than 300 pg/mL) indicates cardiac origin of failure
- Sensitivity 85%, specificity 80% for WiPO
Echocardiography performed during SBT:
- Increased E/e' ratio (greater than 15 indicates elevated LV filling pressures)
- New or worsening wall motion abnormalities (suggests ischemia)
- May demonstrate diastolic dysfunction

Acceptable alternatives:

Lung ultrasound during SBT: Appearance of B-lines (vertical artifacts indicating interstitial edema)
Pulmonary artery catheter (if in situ): Rise in PCWP during SBT (greater than 18 mmHg)

(c) Management Strategies (4 marks - 1 per strategy):

**"Dry Weaning"

Aggressive Diuresis:**
- Furosemide IV to achieve negative fluid balance 500-1000 mL/day for 2-3 days before next SBT attempt
- Target: Even to slightly negative cumulative fluid balance
- Monitor daily weights, strict input/output
- Rationale: Reduces preload, lowers baseline PCWP

Afterload Reduction:
- ACE inhibitor (e.g., enalaprilat IV or start oral if gut function intact)
- OR Nitrates (nitroglycerin infusion during SBT if hypertensive)
- Rationale: Reduces systemic vascular resistance, decreases LV workload
Optimize Heart Failure Therapy:
- Beta-blocker (if not already on, once stable - controls HR, reduces myocardial O₂ demand)
- Treat myocardial ischemia if present (antiplatelet, statin, consider cardiology consult)
- Correct anemia (target Hb greater than 8-9 g/dL)
Post-Extubation Prophylactic NIV:
- Plan for immediate transition to NIV (BiPAP or CPAP) upon successful SBT and extubation
- Settings: CPAP 5-8 cmH₂O OR BiPAP IPAP 10-12, EPAP 5-8
- Rationale: Maintains positive intrathoracic pressure post-extubation, prevents sudden afterload increase, reduces reintubation risk

Alternative acceptable answers: Gradual PSV weaning (reduce by 2 cmH₂O daily) rather than abrupt SBT; Correct electrolytes (K⁺, Mg²⁺); Ensure adequate nutrition without overfeeding.

SAQ 3: Cuff Leak Test and Post-Extubation Stridor

Question: A 55-year-old man has been intubated for 10 days following ARDS. He passes a 60-minute spontaneous breathing trial and meets all extubation criteria. You decide to perform a cuff leak test before extubation.

(a) List FOUR indications for performing a cuff leak test. (2 marks)

(b) Describe the quantitative technique for performing a cuff leak test. (4 marks)

(c) The cuff leak volume is measured at 80 mL (tidal volume 500 mL). Interpret this result and outline your management. (4 marks)

Model Answer:

(a) Indications for Cuff Leak Test (2 marks - 0.5 per indication, any 4):

Prolonged intubation (greater than 48 hours)
Traumatic or multiple intubation attempts
Large endotracheal tube relative to patient size (concern for airway edema)
History of airway surgery or known laryngeal pathology
Self-extubation attempts (airway trauma)
Fluid overload/positive fluid balance (systemic edema → laryngeal edema)
Female gender (smaller airway diameter)

(b) Quantitative Cuff Leak Test Technique (4 marks):

Preparation:
- Set ventilator to volume control mode
- Suction oropharynx and endotracheal tube thoroughly (prevents aspiration) (1 mark)
Baseline Measurement:
- Record the delivered inspiratory tidal volume (Vt inspiratory) from ventilator (1 mark)
Perform Test:
- Deflate the endotracheal tube cuff completely
- Allow 6 breaths for stabilization (1 mark)
Calculate Leak:
- Measure the expired tidal volume (Vt expiratory)
- Cuff leak volume = Vt (inspiratory) - Vt (expiratory)
- OR Calculate as percentage: [Leak volume ÷ Vt inspiratory] × 100% (1 mark)

(c) Interpretation and Management (4 marks):

Interpretation (2 marks):

Cuff leak volume: 80 mL (16% of 500 mL tidal volume)
Threshold for low-risk: greater than 110 mL OR greater than 12-24% of tidal volume
This result: BORDERLINE to LOW LEAK (80 mL is below 110 mL threshold) (1 mark)
Interpretation: Moderate-to-high risk of post-extubation stridor and upper airway obstruction due to likely laryngeal edema (1 mark)

Management (2 marks):

Administer Systemic Corticosteroids: (1 mark)
- Methylprednisolone 20-40 mg IV every 6 hours, OR
- Dexamethasone 5 mg IV every 6 hours
- Duration: 4-24 hours (at least 4 doses recommended)
- Rationale: Reduces laryngeal edema, improves cuff leak
Delay Extubation and Repeat Test: (0.5 marks)
- Defer extubation for 12-24 hours
- Repeat cuff leak test after corticosteroid course
- Proceed with extubation if repeat test shows improvement (leak greater than 110 mL)
Prepare for Difficult Airway if Extubation Proceeds: (0.5 marks)
- If clinical urgency requires extubation despite failed test
- Ensure difficult airway equipment at bedside
- Have experienced intubator available
- Consider ENT/anesthesia standby
- Post-extubation: Nebulized epinephrine (racemic epi 0.5 mL of 2.25% in 3 mL NS) if stridor develops

SAQ 4: Prolonged Weaning and Tracheostomy

Question: A 68-year-old woman with severe COPD has been mechanically ventilated for 14 days following pneumonia and septic shock. She has now failed four spontaneous breathing trials over the past 8 days. Her original infection has resolved, and she is hemodynamically stable off vasopressors. She is alert and cooperative.

(a) Using the International Consensus Conference classification, categorize her weaning status and state the typical prognosis for this group. (2 marks)

(b) List SIX reversible causes of difficult/prolonged weaning that should be systematically assessed. (3 marks)

(c) Discuss the role and timing of tracheostomy in this patient, including benefits and risks. (5 marks)

Model Answer:

(a) Weaning Classification and Prognosis (2 marks):

Classification: Prolonged Weaning (Group 3) (1 mark)

Definition: Failed ≥3 SBTs (she has failed 4) OR weaning duration greater than 7 days from first SBT (she is 8 days in)

Prognosis:

Represents 10-15% of mechanically ventilated patients
ICU mortality: 30-40%
1-year mortality: greater than 50%
Significantly higher morbidity, longer ICU/hospital stay (1 mark)

(b) Six Reversible Causes of Prolonged Weaning (3 marks - 0.5 per cause):

Respiratory: Bronchospasm, secretions, auto-PEEP (especially in COPD), persistent hypoxemia
Cardiac: LV dysfunction, weaning-induced pulmonary edema, myocardial ischemia, fluid overload
Neuromuscular: ICU-acquired weakness (critical illness polyneuropathy/myopathy), ventilator-induced diaphragmatic dysfunction (VIDD), residual sedation
Metabolic: Hypophosphatemia, hypokalemia, hypomagnesemia, hypothyroidism, adrenal insufficiency
Nutritional: Overfeeding (↑ VCO₂ production), underfeeding (muscle wasting), refeeding syndrome
Psychological: Delirium, anxiety, depression, lack of sleep
Infection: Ventilator-associated pneumonia, sepsis

(Any 6 of above)

(c) Tracheostomy - Role, Timing, Benefits, Risks (5 marks):

Timing in This Patient (1 mark):

Recommend tracheostomy now (Day 14 of ventilation, prolonged weaning established)
Current evidence suggests early tracheostomy = 7-10 days; late = greater than 10-14 days
At day 14 with failed weaning attempts, she is an ideal candidate
Her underlying severe COPD suggests prolonged weaning likely (greater than 21 days total ventilation)

Benefits (2 marks - 0.5 each, any 4):

Physiological:

Reduced dead space (50-70 mL less than ETT) → improved CO₂ clearance (important in COPD)
Lower airway resistance (shorter, wider tube) → reduced work of breathing (15-30% reduction)
Easier secretion clearance

Patient Comfort/Care:

Reduced sedation requirements → less delirium, better cooperation with weaning
Allows phonation with speaking valve → improved communication, psychological benefit
Oral nutrition possible → better nutritional status
Better oral hygiene
Facilitates mobilization → reduces ICU-acquired weakness

System:

Shorter ICU stay (can transfer to step-down/weaning unit)
Allows discharge to Long-Term Acute Care Hospital (LTACH) or specialized weaning center if prolonged weaning continues

Risks (1 mark - 0.25 each, any 4):

Early/Procedural:

Bleeding (5-10% incidence)
Pneumothorax (1-5%)
Tube misplacement
Stomal infection (5-15%)

Late:

Tracheal stenosis (1-2% with modern percutaneous technique)
Tracheomalacia
Tracheoinnominate artery fistula (rare below 1%, high mortality if occurs)

Patient-Specific Consideration (1 mark):

Benefits likely outweigh risks in this patient
Expected to improve comfort, facilitate weaning in context of severe COPD and prolonged ventilation
Should discuss with patient (she is alert and cooperative) and family
Emphasize that tracheostomy is NOT "giving up"
most patients eventually decannulate
Explain improved comfort, ability to speak, eat, mobilize

Viva Scenarios

Viva 1: Weaning Assessment and RSBI

Scenario: You are the ICU consultant. A 58-year-old man has been ventilated for 4 days with severe pneumonia. The respiratory therapist asks if he is ready for weaning. Current settings: PSV 12 cmH₂O, PEEP 8 cmH₂O, FiO₂ 40%. ABG: pH 7.38, PaCO₂ 42, PaO₂ 85, HCO₃⁻ 24. Alert, follows commands, HR 95, BP 128/76, no vasopressors.

Examiner Questions:

"How do you assess if this patient is ready for a weaning trial?"
"The RSBI is 115. What does this mean? Would you still proceed with an SBT?"
"He starts the SBT but after 15 minutes becomes tachypneic (RR 36), tachycardic (HR 125), and diaphoretic. What do you do?"

Model Answer:

Question 1: Weaning Readiness Assessment

"I use a systematic approach based on four domains:

1. Oxygenation:

Calculate PaO₂/FiO₂: 85/0.4 = 213 mmHg - meets threshold of ≥150-200 ✓
FiO₂ 40% - meets ≤40-50% ✓
PEEP 8 cmH₂O - borderline, prefer ≤5-8, but acceptable ✓
pH normal at 7.38 ✓

2. Hemodynamic Stability:

HR 95, BP 128/76 - stable ✓
No vasopressors ✓

3. Neurological:

Alert, follows commands ✓
Would assess cough strength, secretion burden at bedside

4. Resolution of Illness:

Day 4 of pneumonia - would confirm clinical improvement (fever trend, WCC, CXR, need to examine patient)

If all criteria met, I would measure RSBI before proceeding to SBT."

Question 2: RSBI Interpretation

"RSBI is calculated as respiratory rate divided by tidal volume in liters, measured on minimal support (CPAP 5 cmH₂O or T-piece) for 1 minute.

An RSBI of 115 is above the classic threshold of 105, which traditionally predicts weaning failure. The optimal threshold with better specificity is below 76.

However, RSBI has:

High negative predictive value (~95%): RSBI below 105 predicts success well
Low positive predictive value (~60%): RSBI greater than 105 does NOT reliably predict failure

My approach with RSBI 115:

I would still proceed with an SBT, but with heightened vigilance
Many patients with RSBI 105-120 successfully wean, especially if other parameters favorable
The SBT is the definitive test - RSBI helps predict but should not be absolute contraindication
I would use PSV 5-8 cmH₂O + PEEP 5 method (easier than T-piece), monitor closely for 30-60 minutes
If patient develops signs of failure, I will stop immediately

Factors that might falsely elevate RSBI: Anxiety, pain, baseline tachypnea (e.g., metabolic acidosis), chronic conditions like COPD."

Question 3: SBT Failure - Management

"This patient is failing the SBT. I would:

Immediate Action:

Stop the SBT immediately - do not let patient struggle
Return to comfortable ventilator settings (PSV 12, PEEP 8, FiO₂ 40% as before)
Provide reassurance to patient
Monitor for stabilization

Assessment:

Examine patient: Work of breathing, accessory muscle use, lung auscultation (crackles? wheeze?), volume status
Check ABG during or just after failed SBT: Look for hypoxemia, rising PaCO₂, acidosis
Review fluid balance: Positive balance could indicate pulmonary edema
12-lead ECG: Look for ischemic changes (HR rose to 125, suggests cardiac stress)

Systematic Evaluation of Causes (WEANABLE mnemonic):

Respiratory:

Bronchospasm? → Bronchodilators
Secretions? → Suctioning, chest physiotherapy
Pulmonary edema? → Diuresis

Cardiac:

Weaning-induced pulmonary edema? (tachycardia, diaphoresis are clues)
Check BNP, consider echo
If suspected: Diuresis, afterload reduction, plan for prophylactic NIV post-extubation

Neuromuscular:

Diaphragm weakness? → Consider ultrasound, PImax measurement
ICU-acquired weakness? → Optimize nutrition, early mobilization

Metabolic:

Check electrolytes (PO₄³⁻, K⁺, Mg²⁺) - correct to high-normal

Anxiety:

Patient distress - dexmedetomidine may help (preserves respiratory drive)

Plan:

Address reversible factors overnight
Repeat daily SBT screen tomorrow
If multiple failures, consider tracheostomy discussion (but still early at day 4)

Examiner may ask: "Would you measure BNP?" **Yes, compare before and after SBT to assess for cardiac contribution. Rise greater than 50% or greater than 300 pg/mL suggests WiPO."

Viva 2: Difficult Weaning in COPD

Scenario: A 72-year-old woman with severe COPD (FEV₁ 35% predicted, on home oxygen 2L continuously) was intubated 8 days ago for hypercapnic respiratory failure triggered by pneumonia. She has now failed three SBTs. During trials, her respiratory rate rises to 32-35, she becomes agitated, and ABG shows pH 7.28, PaCO₂ 68 (baseline 55), PaO₂ 65 on FiO₂ 50%.

Examiner Questions:

"What is the classification of her weaning status? What are the specific challenges of weaning COPD patients?"
"Explain the pathophysiology of auto-PEEP in COPD and how it affects weaning."
"Describe your management plan to facilitate successful weaning in this patient, including the role of NIV."

Model Answer:

Question 1: Classification and COPD-Specific Challenges

Classification: "This is Difficult Weaning (Group 2), trending toward Prolonged Weaning (Group 3):

Failed 3 SBTs (threshold for prolonged is ≥3)
Currently on day 8 of weaning attempts (prolonged defined as greater than 7 days)
If she fails additional SBTs, she will definitively be Group 3

COPD-Specific Challenges:

1. Chronic Respiratory Insufficiency:

Baseline hypercapnia (55 mmHg) with metabolic compensation (elevated HCO₃⁻)
Must tolerate higher PaCO₂ during weaning - focus on pH, not absolute CO₂
Her SBT showed pH 7.28 (acidotic) - this indicates inadequate compensation, true failure

2. Auto-PEEP (Intrinsic PEEP):

Air trapping due to obstructed exhalation
Creates internal positive pressure - difficult to trigger ventilator
Increases work of breathing dramatically

3. Increased Work of Breathing:

Hyperinflation flattens diaphragm → poor mechanical advantage
High airway resistance
Rapid fatigue

4. Cardiac Issues:

Cor pulmonale from chronic hypoxemia
Risk of weaning-induced pulmonary edema
Home oxygen dependence suggests significant baseline impairment

5. Nutritional/Muscular:

Chronic illness often → cachexia, muscle wasting
Diaphragm weakness common"

Question 2: Auto-PEEP Pathophysiology

"Auto-PEEP (Intrinsic PEEP) Mechanism:

Normal Physiology:

Expiration is passive, driven by elastic recoil
Alveolar pressure returns to atmospheric (zero) before next breath

In COPD:

Airway obstruction (bronchospasm, mucus, loss of elastic recoil, dynamic airway collapse)
Expiratory flow limited
Exhalation incomplete before next breath triggered
Air trapped in alveoli → positive alveolar pressure at end-expiration
This trapped pressure = auto-PEEP (typically 5-15 cmH₂O in severe COPD)

Effect on Weaning:

Increased Inspiratory Threshold Load:

Before patient can generate flow to trigger ventilator, they must first overcome auto-PEEP
Example: If auto-PEEP = 10 cmH₂O and trigger sensitivity = -2 cmH₂O, patient must generate -12 cmH₂O effort
Essentially doing 'extra work' before breath even starts

Increased Work of Breathing:

Oxygen cost of breathing increases 2-10 fold
Diaphragm fatigues rapidly
Patient becomes tachypneic, further worsening air trapping (vicious cycle)

Clinical Manifestation:

Patient 'fighting' ventilator
Tachypnea (trying to compensate for low tidal volumes)
Respiratory acidosis (inadequate minute ventilation)
Agitation, diaphoresis (respiratory distress)

Measurement:

Expiratory hold maneuver on ventilator reveals auto-PEEP level"

Question 3: Management Plan

"My approach involves optimizing respiratory mechanics, gradual weaning, and planning for NIV bridge.

Immediate Strategies:

1. Offset Auto-PEEP with Applied PEEP:

Measure auto-PEEP (expiratory hold)
If auto-PEEP = 10 cmH₂O, set external PEEP to 8 cmH₂O (80% of auto-PEEP)
This 'opens the door' earlier, reduces inspiratory threshold
Does NOT worsen hyperinflation if set correctly

2. Optimize Bronchodilation:

Inhaled beta-agonists (salbutamol) + anticholinergics (ipratropium) q4-6h
Consider IV magnesium sulfate if severe bronchospasm
Ensure adequate humidification

3. Manage Secretions:

Aggressive chest physiotherapy
Suctioning (but avoid excessive suctioning → bronchospasm)
Adequate hydration

4. Permissive Hypercapnia:

Accept PaCO₂ 55-65 mmHg (her baseline is 55)
Target pH ≥7.30-7.32, NOT normocapnia
During next SBT, pH 7.28 indicates failure, but PaCO₂ 68 alone would be acceptable if pH ≥7.30

Weaning Strategy:

5. SBT Method:

Use PSV (not T-piece) - better tolerated in COPD
PSV 5-8 cmH₂O + PEEP 8 cmH₂O (to offset auto-PEEP)
Duration: Start with shorter trials (30 min), extend if tolerated

Alternatively: Gradual PSV Weaning:

Instead of abrupt SBT, reduce PSV by 2 cmH₂O every 12-24 hours
Target PSV 5-8 before extubation attempt
May take days but avoids exhausting patient

6. Address Metabolic/Nutritional Factors:

Check electrolytes: Correct PO₄³⁻, K⁺, Mg²⁺ to high-normal
Nutrition: Avoid overfeeding (↑ VCO₂), avoid underfeeding (muscle wasting)
- Prefer high-fat, lower-carbohydrate formula
Ensure adequate protein (1.2-2.0 g/kg/day)

7. Early Mobilization:

Physical therapy, sitting, standing
Reduces ICU-acquired weakness

8. Minimize Sedation:

Keep awake, cooperative (RASS 0 to -1)
Avoid benzodiazepines (respiratory depression)

Non-Invasive Ventilation (NIV) Strategy:

9. Early Extubation to NIV (Bridge to Extubation):

This is KEY in COPD difficult weaning
If she fails one more SBT but is otherwise stable (alert, manageable secretions, hemodynamically stable)
Extubate directly to NIV (BiPAP) rather than prolonging invasive ventilation

NIV Protocol:

BiPAP settings: IPAP 12-15 cmH₂O, EPAP 5-8 cmH₂O (matches auto-PEEP)
FiO₂ titrated to SpO₂ 88-92% (avoid hyperoxia in COPD - can suppress respiratory drive)
Continuous NIV for first 12-24 hours, then gradually reduce duration
Target: pH greater than 7.30, PaCO₂ near baseline (55 mmHg acceptable)

Evidence:

NIV as weaning bridge in COPD reduces VAP, ICU stay, mortality
More effective than continuing invasive ventilation

Tracheostomy Consideration:

10. If Above Strategies Fail:

She is day 8, approaching threshold for tracheostomy discussion
If she fails 2-3 more SBTs despite optimization, consider tracheostomy (day 10-14)
Benefits in COPD: Reduced dead space (↑ CO₂ clearance), lower resistance (↓ work of breathing), comfort, facilitates transfer to weaning unit
Discuss with patient (if capacity) and family

Examiner may probe: 'Why not just do NIV now?' **Answer: She is still day 8, invasive ventilation protects airway, allows time to optimize. NIV is planned as bridge once she demonstrates near-readiness (e.g., tolerates 20-30 min SBT even if not full 60 min). If we extubate to NIV too early and she fails, reintubation carries high mortality. Timing is critical - need to balance avoiding prolonged intubation vs premature extubation.'"

References

Boles JM, et al. Weaning from mechanical ventilation. Eur Respir J. 2007;29(5):1033-1056. PMID: 17470624
Schmidt GA, et al. Official Executive Summary of an American Thoracic Society/American College of Chest Physicians Clinical Practice Guideline: Liberation from Mechanical Ventilation in Critically Ill Adults. Am J Respir Crit Care Med. 2017;195(1):115-119. PMID: 28007789
Ouellette DR, et al. Liberation From Mechanical Ventilation in Critically Ill Adults: An Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline. Chest. 2017;151(1):166-180. PMID: 27818331
MacIntyre NR, et al. Evidence-based guidelines for weaning and discontinuing ventilatory support: a collective task force facilitated by the American College of Chest Physicians. Chest. 2001;120(6 Suppl):375S-395S. PMID: 11742959
Yang KL, Tobin MJ. A prospective study of indexes predicting the outcome of trials of weaning from mechanical ventilation. N Engl J Med. 1991;324(21):1445-1450. PMID: 1585971
Esteban A, et al. A comparison of four methods of weaning patients from mechanical ventilation. N Engl J Med. 1995;332(6):345-350. PMID: 7823995
Subira C, et al. Effect of Pressure Support vs T-Piece Ventilation Strategies During Spontaneous Breathing Trials on Successful Extubation Among Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial. JAMA. 2019;321(22):2175-2182. PMID: 31157897
Boles JM, et al. Weaning from mechanical ventilation. Eur Respir J. 2007;29(5):1033-1056. PMID: 17470624
Beduneau G, et al. Epidemiology of Weaning Outcome according to a New Definition. The WIND Study. Am J Respir Crit Care Med. 2017;195(6):772-783. PMID: 27626706
Ochoa ME, et al. Cuff-leak test for the diagnosis of upper airway obstruction in adults: a systematic review and meta-analysis. Intensive Care Med. 2009;35(7):1171-1179. PMID: 19399474
Kuriyama A, et al. Prophylactic Corticosteroids for Prevention of Postextubation Stridor and Reintubation in Adults: A Systematic Review and Meta-analysis. Chest. 2017;151(5):1002-1010. PMID: 28212836
Hernández G, et al. Effect of Postextubation High-Flow Nasal Cannula vs Conventional Oxygen Therapy on Reintubation in Low-Risk Patients: A Randomized Clinical Trial. JAMA. 2016;315(13):1354-1361. PMID: 26975498
Nava S, et al. Noninvasive ventilation to prevent respiratory failure after extubation in high-risk patients. Crit Care Med. 2005;33(11):2465-2470. PMID: 16276167
Thille AW, et al. Effect of Postextubation High-Flow Nasal Oxygen With Noninvasive Ventilation vs High-Flow Nasal Oxygen Alone on Reintubation Among Patients at High Risk of Extubation Failure: A Randomized Clinical Trial. JAMA. 2019;322(15):1465-1475. PMID: 31577036
Epstein SK, et al. Effect of failed extubation on the outcome of mechanical ventilation. Chest. 1997;112(1):186-192. PMID: 9228375
Esteban A, et al. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA. 2002;287(3):345-355. PMID: 11790214
Esteban A, et al. Evolution of mortality over time in patients receiving mechanical ventilation. Am J Respir Crit Care Med. 2013;188(2):220-230. PMID: 23631814
Levine S, et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008;358(13):1327-1335. PMID: 18367735
Jubran A, et al. Weaning prediction: esophageal pressure monitoring complements readiness testing. Am J Respir Crit Care Med. 2005;171(11):1252-1259. PMID: 15764731
Tobin MJ, et al. The pattern of breathing during successful and unsuccessful trials of weaning from mechanical ventilation. Am Rev Respir Dis. 1986;134(6):1111-1118. PMID: 3789520
Lemaire F, et al. Acute left ventricular dysfunction during unsuccessful weaning from mechanical ventilation. Anesthesiology. 1988;69(2):171-179. PMID: 3407967
Hurford WE, et al. Myocardial perfusion as assessed by thallium-201 scintigraphy during the discontinuation of mechanical ventilation in ventilator-dependent patients. Anesthesiology. 1991;74(6):1007-1016. PMID: 2042754
Liu J, et al. Weaning-induced cardiac dysfunction: mechanism and clinical relevance. Ann Am Thorac Soc. 2018;15(Suppl 1):S35-S40. PMID: 29676632
Goligher EC, et al. Evolution of Diaphragm Thickness during Mechanical Ventilation. Impact of Inspiratory Effort. Am J Respir Crit Care Med. 2015;192(9):1080-1088. PMID: 26167730
Stevens RD, et al. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 2007;33(11):1876-1891. PMID: 17639340
Heunks LM, et al. Clinical review: the ABC of weaning failure--a structured approach. Crit Care. 2010;14(6):245. PMID: 21143773
Tobin MJ, Jubran A. Variable performance of weaning-predictor tests: role of Bayes' theorem and spectrum and test-referral bias. Intensive Care Med. 2006;32(12):2002-2012. PMID: 17019549
Burns KEA, et al. Trials directly comparing alternative spontaneous breathing trial techniques: a systematic review and meta-analysis. Crit Care. 2017;21(1):127. PMID: 28535812
Harikumar G, et al. Pressure-time product and maximum inspiratory pressure in predicting extubation outcome. Intensive Care Med. 2009;35(8):1441-1446. PMID: 19506837
Sassoon CS, et al. Airway occlusion pressure and breathing pattern as predictors of weaning outcome. Am Rev Respir Dis. 1993;148(4 Pt 1):860-866. PMID: 8214941
Alberti A, et al. P0.1 is a useful parameter in setting the level of pressure support ventilation. Intensive Care Med. 1995;21(7):547-553. PMID: 7593896
DiNino E, et al. Diaphragm ultrasound as a predictor of successful extubation from mechanical ventilation. Thorax. 2014;69(5):423-427. PMID: 24365607
Ferrari G, et al. Diaphragm ultrasound as a new index of discontinuation from mechanical ventilation. Crit Ultrasound J. 2014;6(1):8. PMID: 24949192
Goligher EC, et al. Measuring diaphragm thickness with ultrasound in mechanically ventilated patients: feasibility, reproducibility and validity. Intensive Care Med. 2015;41(4):642-649. PMID: 25693448
Esteban A, et al. Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings. Ann Intern Med. 2004;141(6):440-445. PMID: 15381517
Perren A, et al. Comparison of 30 versus 120 minutes spontaneous breathing trial for weaning from mechanical ventilation: a randomized clinical trial. Intensive Care Med. 2002;28(8):1058-1063. PMID: 12185425
Jubran A, et al. Effect of pressure support vs unassisted breathing through a tracheostomy collar on weaning duration in patients requiring prolonged mechanical ventilation: a randomized trial. JAMA. 2013;309(7):671-677. PMID: 23403979
Jaber S, et al. Post-anaesthesia pulmonary complications after abdominal surgery. Respir Res. 2006;7:98. PMID: 16813655
François B, et al. 12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomised double-blind trial. Lancet. 2007;369(9567):1083-1089. PMID: 17398307
Smina M, et al. Cough peak flows and extubation outcomes. Chest. 2003;124(1):262-268. PMID: 12853533
Thille AW, et al. Outcomes of extubation failure in medical intensive care unit patients. Crit Care Med. 2011;39(12):2612-2618. PMID: 21765357
Maggiore SM, et al. Nasal high-flow versus Venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome. Am J Respir Crit Care Med. 2014;190(3):282-288. PMID: 25003980
Ferrer M, et al. Noninvasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial. Lancet. 2009;374(9695):1082-1088. PMID: 19682735
Heunks LM, et al. Clinical review: the ABC of weaning failure--a structured approach. Crit Care. 2010;14(6):245. PMID: 21143773
Blackwood B, et al. Protocolized versus non-protocolized weaning for reducing the duration of mechanical ventilation in critically ill adult patients. Cochrane Database Syst Rev. 2014;(11):CD006904. PMID: 25387992
De Jonghe B, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288(22):2859-2867. PMID: 12472328
Girard TD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126-134. PMID: 18191684
Zapata L, et al. B-type natriuretic peptides for prediction and diagnosis of weaning failure from cardiac origin. Intensive Care Med. 2011;37(3):477-485. PMID: 21152896
Soummer A, et al. Ultrasound assessment of lung aeration loss during a successful weaning trial predicts postextubation distress. Crit Care Med. 2012;40(7):2064-2072. PMID: 22584759
Ely EW, et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med. 1996;335(25):1864-1869. PMID: 8948561
Blackwood B, et al. Use of weaning protocols for reducing duration of mechanical ventilation in critically ill adult patients: Cochrane systematic review and meta-analysis. BMJ. 2011;342:c7237. PMID: 21233157
Pun BT, et al. Caring for Critically Ill Patients with the ABCDEF Bundle: Results of the ICU Liberation Collaborative in Over 15,000 Adults. Crit Care Med. 2019;47(1):3-14. PMID: 30339549
Pandharipande PP, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298(22):2644-2653. PMID: 18073360
Schweickert WD, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373(9678):1874-1882. PMID: 19446324
Young D, et al. Effect of early vs late tracheostomy placement on survival in patients receiving mechanical ventilation: the TracMan randomized trial. JAMA. 2013;309(20):2121-2129. PMID: 23695482
Meng L, et al. Early vs late tracheostomy in critically ill patients: a systematic review and meta-analysis. Clin Respir J. 2016;10(6):684-692. PMID: 25757567
Griffiths J, et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res. 2019;6(1):e000420. PMID: 31258917
Nava S, et al. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial. Ann Intern Med. 1998;128(9):721-728. PMID: 9556464
Ferrer M, et al. Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial. Am J Respir Crit Care Med. 2006;173(2):164-170. PMID: 16224108
Pelosi P, et al. The effects of body mass on lung volumes, respiratory mechanics, and gas exchange during general anesthesia. Anesth Analg. 1998;87(3):654-660. PMID: 9728848
Fernandez-Bustamante A, et al. Postoperative Pulmonary Complications, Early Mortality, and Hospital Stay Following Noncardiothoracic Surgery: A Multicenter Study by the Perioperative Research Network Investigators. JAMA Surg. 2017;152(2):157-166. PMID: 27829093
Rabinstein AA, et al. Mechanical ventilation in patients with Guillain-Barre syndrome. Neurocrit Care. 2004;1(3):319-324. PMID: 16174927
Frutos-Vivar F, et al. Risk factors for extubation failure in patients following a successful spontaneous breathing trial. Chest. 2006;130(6):1664-1671. PMID: 17166980

Clinical board

Linked comparisons

Weaning from Mechanical Ventilation

Quick Answer

CICM Exam Focus

Written Exam (SAQ/MCQ)

Viva/Oral Exam

Key Points

Core Concepts

Clinical Overview

Epidemiology

Pathophysiology

Transition from Positive Pressure to Spontaneous Breathing

Respiratory System Changes

Cardiovascular Changes

Ventilator-Induced Diaphragmatic Dysfunction (VIDD) [18,24]

Neuromuscular Factors

Assessment: Weaning Readiness

Systematic Approach: The Four Domains [4,26]

1. Oxygenation and Gas Exchange

2. Hemodynamic Stability

3. Neurological and Airway Protection

4. Resolution of Precipitating Illness

Weaning Predictors

Rapid Shallow Breathing Index (RSBI) [5,27,28]

Maximal Inspiratory Pressure (PImax/NIF) [29]

Airway Occlusion Pressure (P0.1) [30,31]

Diaphragm Ultrasound [32,33,34]

Spontaneous Breathing Trial (SBT)

Indications [2,4]

SBT Methods [6,7,35]

Option 1: Pressure Support Ventilation (PSV) - PREFERRED

Option 2: T-Piece Trial

Option 3: CPAP (Continuous Positive Airway Pressure)

SBT Duration [36]

SBT Failure Criteria [4,37]

Post-SBT Decision Making

Extubation Procedure

Pre-Extubation Assessment

Cuff Leak Test [10,11,38]

Airway Secretion Assessment

Extubation Checklist

Post-Extubation Respiratory Support

Risk Stratification [12,13,41]

Low-Risk Patients

High-Risk Patients (≥1 of following)

Modalities

High-Flow Nasal Cannula (HFNC) [12,42]

Non-Invasive Ventilation (NIV) [13,43]

Combined NIV + HFNC Protocol [14]

Difficult Weaning

Definition [8,9]

Causes of Weaning Failure [44,45]

W - Work of Breathing (Increased)

E - Endocrine/Metabolic

A - Airway/Anxiety

N - Neuromuscular Weakness [25,46]

A - Acidosis/Alkalosis

B - Brain/Neurological

L - Left Ventricular Dysfunction [21,22,23]

E - Excessive Nutrition/Energy Imbalance

Management Strategies for Difficult Weaning

1. Daily Multidisciplinary Assessment

2. Protocolized Weaning [50,51]

3. ABCDEF Bundle [52]

4. Sedation Management [47,53]

5. Early Mobilization [54]

Tracheostomy in Prolonged Weaning [55,56,57]

Timing Considerations

Evidence [55,56]

Benefits of Tracheostomy

Risks of Tracheostomy

Current Recommendations [57]

Special Populations

COPD and Hypercapnia [58,59]

Challenges

Management Strategies

Cardiac Dysfunction and Weaning-Induced Pulmonary Edema [21,22,23,48]

Pathophysiology (Detailed)

Diagnosis [48,49]